Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection

被引:33
|
作者
Lagaye, Sylvie [1 ]
Shen, Hong [1 ]
Saunier, Bertrand [1 ]
Nascimbeni, Michelina [1 ]
Gaston, Jesintha [1 ]
Bourdoncle, Pierre
Hannoun, Laurent [2 ]
Massault, Pierre-Philippe [3 ]
Vallet-Pichard, Anais [1 ,4 ]
Mallet, Vincent [1 ,4 ]
Pol, Stanislas [1 ,4 ]
机构
[1] Univ Paris 05, UMR S1016, Equipe Cycle Cellulaire Regenerat & Hepatopathies, Inst Cochin,INSERM,U1016,CNRS,UMR8104, F-75014 Paris, France
[2] Grp Hosp La Pitie Salpetriere, AP HP, Serv Chirurg Digest & Hepato Bilio Pancreat, Paris, France
[3] Hop Hotel Dieu, Grp Hosp Cochin, AP HP, Serv Chirurg Viscerale, Paris, France
[4] Hop Hotel Dieu, Grp Hosp Cochin, AP HP, Unite Hepatol, Paris, France
关键词
HUMAN HEPATOCYTES; CORE PROTEIN; SIGNALING PATHWAYS; CELL-CULTURE; IN-VITRO; EXPRESSION; MICE;
D O I
10.1002/hep.25738
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The development of human cultured hepatitis C virus (HCV) replication-permissive hepatocarcinoma cell lines has provided important new virological tools to study the mechanisms of HCV infection; however, this experimental model remains distantly related to physiological and pathological conditions. Here, we report the development of a new ex vivo model using human adult liver slices culture, demonstrating, for the first time, the ability of primary isolates to undergo de novo viral replication with the production of high-titer infectious virus as well as Japanese fulminant hepatitis type 1, H77/C3, and Con1/C3. This experimental model was employed to demonstrate HCV neutralization or HCV inhibition, in a dose-dependent manner, either by cluster of differentiation 81 or envelope protein 2specific antibodies or convalescent serum from a recovered HCV patient or by antiviral drugs. Conclusion: This new ex vivo model represents a powerful tool for studying the viral life cycle and dynamics of virus spread in native tissue and also allows one to evaluate the efficacy of new antiviral drugs. (HEPATOLOGY 2012;56:861872)
引用
收藏
页码:861 / 872
页数:12
相关论文
共 50 条
  • [1] Primary Hepatocyte Culture Supports Hepatitis C Virus Replication: A Model for Infection-Associated Hepatocarcinogenesis
    Banaudha, Krishna
    Orenstein, Jan M.
    Korolnek, Tamara
    St Laurent, Georges C., III
    Wakita, Takaji
    Kumar, Ajit
    HEPATOLOGY, 2010, 51 (06) : 1922 - 1932
  • [2] Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C
    Aoudjehane, Lynda
    Bisch, Gregoire
    Scatton, Olivier
    Granier, Christelle
    Gaston, Jesintha
    Housset, Chantal
    Roingeard, Philippe
    Cosset, Francois-Loic
    Perdigao, Fabiano
    Balladur, Pierre
    Wakita, Takaji
    Calmus, Yvon
    Conti, Filomena
    PLOS ONE, 2015, 10 (07):
  • [3] Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis
    Bility, Moses T.
    Zhang, Liguo
    Washburn, Michael L.
    Curtis, T. Anthony
    Kovalev, Grigoriy I.
    Su, Lishan
    NATURE PROTOCOLS, 2012, 7 (09) : 1608 - 1617
  • [4] Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
    Pearen, Michael A.
    Lim, Hong Kiat
    Gratte, Francis D.
    Fernandez-Rojo, Manuel A.
    Nawaratna, Sujeevi K.
    Gobert, Geoffrey N.
    Olynyk, John K.
    Tirnitz-Parker, Janina E. E.
    Ramm, Grant A.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (157):
  • [5] Hepatitis C virus infection and related liver disease: the quest for the best animal model
    Mailly, Laurent
    Robinet, Eric
    Meuleman, Philip
    Baumert, Thomas F.
    Zeisel, Mirjam B.
    FRONTIERS IN MICROBIOLOGY, 2013, 4
  • [6] Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment
    Bissig, Karl-Dimiter
    Wieland, Stefan F.
    Tran, Phu
    Isogawa, Masanori
    Le, Tam T.
    Chisari, Francis V.
    Verma, Inder M.
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (03) : 924 - 930
  • [7] A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
    Washburn, Michael L.
    Bility, Moses T.
    Zhang, Liguo
    Kovalev, Grigoriy I.
    Buntzman, Adam
    Frelinger, Jeffery A.
    Barry, Walter
    Ploss, Alexander
    Rice, Charles M.
    Su, Lishan
    GASTROENTEROLOGY, 2011, 140 (04) : 1334 - 1344
  • [8] A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression
    Lee, Jaeseo
    Gil, Dayeon
    Park, Hyeyeon
    Lee, Youngsun
    Mun, Seon Ju
    Shin, Yongbo
    Jo, Eunji
    Windisch, Marc P.
    Kim, Jung-Hyun
    Son, Myung Jin
    HEPATOLOGY, 2024, 80 (01) : 186 - 201
  • [9] Interferon signaling in the liver during hepatitis C virus infection
    Makowska, Zuzanna
    Heim, Markus H.
    CYTOKINE, 2012, 59 (03) : 460 - 466
  • [10] Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection
    Irshad, Mohammad
    Gupta, Priyanka
    Irshad, Khushboo
    VIRAL IMMUNOLOGY, 2019, 32 (03) : 112 - 120